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Abstract
This study describes the development of N-benzyl-1,10-phenantrolinium salt as an antiplasmodium agent. The salt, that
is, 1-(4-ethoxy-3-methoxybenzyl)-1,10-phenanthrolin-1-ium bromide, was prepared using vanillin as the starting
material in four simple synthetic steps. First, the alkylation of vanillin using diethyl sulfate produced 4-ethoxy-3methoxybenzaldehyde in 79% yield. Second, the reduction of the protected vanillin by NaBH4 through the grinding
method allowed us to obtain 4-ethoxy-3-methoxybenzyl alcohol in 96% yield. Next, the bromination of the benzyl
alcohol under solvent-free condition led to the formation of the corresponding benzyl bromide, which in turn underwent
bimolecular nucleophilic substitution with 1,10-phenanthroline to produce the desired product, that is, 1-(4-ethoxy-3methoxybenzyl)-1,10-phenanthrolin-1-ium bromide, in 58% yield. The evaluation of N-benzyl-1,10-phenantrolinium
salt as an antiplasmodium agent was conducted through heme polymerization inhibitory activity (HPIA) assay. The
results showed that the phenantroline salt and chloroquine displayed the HPIA half maximal inhibitory concentrations
of 3.63 and 4.37 mM, respectively. Therefore, 1-(4-ethoxy-3-methoxybenzyl)-1,10-phenanthrolin-1-ium bromide
displays desirable HPIA and has a great potential to be further developed as an antiplasmodium.
Keywords: antiplasmodium, HPIA assay, 1,10-phenantroline salt, vanillin

salts, display great potential as antiplasmodium agents
[8–10]. The activity of the drug is also correlated to
their anion counterpart, where large anions, such as
bromide or iodide, may give good antiplasmodium
profile [11–13].

Introduction
Malaria is a global disease affecting developing and
developed countries. According to data from World
Health Organization, 219 million cases of malaria were
diagnosed worldwide, and 435,000 malaria-caused
mortalities were recorded in 2017 [1]. Efforts to overcome
malaria have been carried out for a long time, but the
outcomes are still not optimal. The efforts are mainly
constrained on the resistance of malaria parasites to
standard antimalaria drugs, such as chloroquine and
artemisinin [2,3]. Moreover, the resistance to antimalaria
drugs rapidly spread almost all over the world, prompting
researchers to find new antimalarial candidates [4].

According to the literature, the convenient synthetic
route to access N-benzyl-1,10-phenantrolinium salts is
by nucleophilic substitution between 10-phenantroline
and benzyl halides [14,15]. The former is commercially
available, and the latter may be generated from
benzaldehydes. In connection to our interests on the
application of Indonesian natural products in the
synthesis biologically active products, we have screened
natural products whose major components are
benzaldehyde derivatives and found out that vanillin (4hydroxy-3-methoxybenzaldehyde) should be an excellent
precursor for N-benzyl-1,10-phenantrolinium salts.

Our groups have been developing phenanthrene-basedantiplasmodium agents [5]. The 1,10-phenantroline
scaffolds [6,7], particularly N-benzyl-1,10-phenantrolinium
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In this study, we aimed to develop a new
antiplasmodium agent made of 1,10-phenantrolinium
salt, that is, 1-(4-ethoxy-3-methoxybenzyl)-1,10phenanthrolin-1-ium bromide, by using vanillin. Before
performing the study, the antiplasmodium activity of the
salt was predicted based on the previously formulated
quantitative structure activity relationship (QSAR)
equation [16]. The calculation showed that the predicted
half maximal inhibitory concentration (IC50) value of
salt was 0.01 µM, whereas that of chloroquine was
0.076 µM. Based on the results, 1-(4-ethoxy-3methoxybenzyl)-1,10-phenanthrolin-1-ium
bromide
displays a good antiplasmodium activity.

Materials and Methods
The materials for this study included vanillin, 1,10phenanthroline monohydrate, diethyl sulfate, NaBH4,
PBr3, NaOH, NaHCO3, NaCl, Na2SO4, hematin, acetic
acid,
acetone,
dimethyl
sulfoxide
(DMSO),
dichloromethane, and chloroform. The materials were
purchased from E. Merck and used without purification.
Proton nuclear magnetic resonance (1H-NMR) spectra
were recorded on a 500 MHz JEOL JNM-ECA using
TMS as an internal reference. Chromatogram and mass
spectra were measured on a Shimadzu QP-2010 GC-MS
spectrometer. Infrared spectra were obtained from a
Shimadzu-Prestige 21 spectrophotometer. The melting
point (m.p.) was determined on an Electrothermal 9100
m.p. apparatus and was not corrected.
Synthesis of 4-ethoxy-3-methoxybenzaldehyde 2.
Vanillin 1 (1 equiv. 33 mmol, 5 g) and 12 mL preheated Aquadest were added to a 250 mL three-necked
flask until complete dissolution. As much as 12 mL
aqueous solution of 5 M NaOH was heated until 100 °C
and added to the mixture. Diethyl sulfate (4.6 mL) was
added dropwise to the mixture. After 45 min, 1.3 mL
diethyl sulfate was added to the mixture. The mixture
was heated for 10 min, and 3 mL aqueous solution of 5
M NaOH was dropwise added. The addition of NaOH
solution and diethyl sulfate was repeated until 8.4 mL
diethyl sulfate was consumed. The reaction mixture was
heated for 15 min, rapidly cooled to rt while stirring,
and then extracted thrice with dichloromethane. The
combined organic layers were dried over Na2SO4 and
evaporated under reduced pressure.
Light-brown solid; m.p.: 63 °C–65 °C; isolated yield:
79%; 1H-NMR (500 MHz, CDCl3, ppm): δ 9.81 (CHO,
s, 1H), 7.42 (HAr, d, J = 7.9 Hz, 1H), 7.40 (HAr, d, J =
7.9 Hz, 1H), 6.97 (HAr, s, 1H), 4.21 (CH2, q, J = 7.5
Hz), 3.92 (CH3, s, 3H), 1.51 (CH2, t, J = 7.5 Hz);
Fourier transform infrared spectroscopy (FTIR) (KBr)
νmax: 3078, 2723, 2681, 1683, 1589, 1512, and 1396;
gas chromatography-mass spectrometry (GC-MS) (EI):
m/z (%): 180 [M+], 151 (base peak), 123, 95, and 65.
Makara J. Sci.
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Synthesis of 4-ethoxy-3-methoxybenzyl alcohol 3. A
mixture of 4-ethoxy-3-methoxybenzaldehyde 2 (1
equiv. 10 mmol 1.8 g) and NaBH4 (1 equiv., 10 mmol,
0.38 g) was ground with an agate mortar and a pestle at
rt for 10 min. The reaction was quenched with a
saturated aqueous solution of NaHCO3. The mixture
was then extracted twice with dichloromethane. The
organic layer was dried over Na2SO4 anhydrous and
evaporated under reduced pressure.
Yellow oil; isolated yield: 96%; 1H-NMR (500 MHz,
CDCl3, ppm): δ 6.86–6.99 (HAr, m, 3H), 4.58 (CH2, d, 2H,
J = 5.9 Hz), 4.10 (CH2, q, J = 7.3 Hz, 2H), 3.85 (CH3, s,
3H), 1.46 (CH3, t, J = 7.3 Hz 3H); FTIR (neat) νmax:
3078, 2978, 1597, 1519, 1465, and 1234; GC-MS (EI):
m/z (%): 182 [M+, base peak], 153, 137, 121, and 93.
Synthesis of 4-ethoxy-3-methoxybenzyl bromide 4.
Benzyl alcohol derivative 3 (1 equiv., 10 mmol) was
placed in a 25 mL three-necked flask equipped with a
condenser and a dropping funnel. Phosphorus
tribromide (1 equiv., 10 mmol, 0.95 mL) was added
dropwise at 0 °C, and the mixture was stirred for 30 min
in an ice bath at rt for 1 h. The reaction was then
refluxed for 3 h. Next, cold water (15 mL) was added to
the reaction mixture. The mixture was then extracted
with chloroform for three times. The organic layer was
dried over Na2SO4 anhydrous and evaporated under
reduced pressure to yield benzyl bromide derivative 4,
which was directly used in the next step without further
purification.
Dark brown oil; isolated yield: 97%; GC-MS (EI): m/z
(%): 244 [M+], 165, 151, 137 (base peak), and 77.
Synthesis of 1-(4-ethoxy-3-methoxybenzyl)-1,10phenanthrolin-1-ium bromide 5. Benzyl bromide
derivative
4
(1
mmol),
1,10-phenanthroline
monohydrate (1 equiv., 1 mmol, 0.2 g), and 15 mL
acetone were introduced to a 100 mL three-necked
flask. The mixture was refluxed for 12 h and then
cooled to rt. The precipitate was then washed with
acetone to yield 1-(4-ethoxy-3-methoxybenzyl)-1,10phenanthrolin-1-ium bromide 5.
Yellow solid; m.p.: 178 °C–183 °C; isolated yield: 58%;
1
H-NMR (500 MHz, DMSO-d6, ppm): δ: 9.75 (HAr, d, J
= 8.5 Hz, 1H), 9.48 (HAr, d, J = 8.5 Hz, 1H), 9.30 (HAr,
d, J = 7.8 Hz, 1H), 8.78 (HAr, d, J = 7.8 Hz, 1H), 8.50
(HAr, d, J = 8.5 Hz, 1H), 8.35–8.37 (HAr, m, 1H), 8.05
(HAr, d, J = 7.8 Hz, 1H), 7.28 (CH2, s, 2H), 7.17 (HAr, s,
1H), 6.77 (HAr, d, J = 8.5 Hz, 1H), 6.63 (HAr, d, J = 8.5
Hz, 1H), 3.87 (CH2, q, J = 7.1 Hz, 2H), 3.71 (CH3, s,
3H), 1.25 (CH3, t, J = 7.1 Hz, 3H); FTIR (KBr) νmax:
3032, 2985, 1597, 1512, 1465, and 1265.
Heme polymerization inhibitory activity (HPIA) assay
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1-ium bromide 5. The in vitro antiplasmodium assay
was carried out through HPIA assay, which was
developed by Basilico [17], by slightly modifying the
hematin solution and sample dosages. As much as 100
mL solution of 1 mM hematin in 0.2 M NaOH was
introduced into a microtube. Next, 50 mL 1,10phenantroline salt 5 with various dose levels of 20, 10,
5, 2.5, and 1.25 mg/mL was added to the solution. The
assay was performed in triplicate for each dose.
To initiate the heme polymerization reaction, we added
50 mL glacial acetic acid solution (pH 2.6) to the
microtube containing the hematin solution and sample.
The microtube was incubated at 37 °C for 24 h. In this
study, chloroquine diphosphate was used as the positive
control and distilled water as the negative control.
After incubation at 37 °C for 24 h, the microtube was
centrifuged at 8000 rpm for 10 min to obtain the
supernatant and precipitate. The former was removed,
whereas the latter was washed thrice with 200 mL
DMSO. The precipitate was then treated with 200 mL
0.1 M NaOH. Each 100 mL of the obtained solution was
placed in a 96-well microplate. The determination of
optical density values was carried out by means of an
ELISA reader at 405 nm.
The HPIA was expressed as IC50, i.e., the concentration
which can allow the inhibition of heme polymerization
by 50% compared with the negative control. The
standard curve was generated by preparing the
concentrations of hematin series (which was dissolved
in 0.2 M NaOH). The IC50 of phenanthroline salt was
calculated using the probit analysis.

Results and Discussion
In this report, we synthesized a new antiplasmodium
agent of 1,10-phenantrolinium salt, that is, 1-(4-ethoxy3-methoxybenzyl)-1,10-phenanthrolin-1-ium bromide,
from vanillin. Vanillin offers several advantages, such
as good availability and accessibility, as a precursor in
synthetic processes. From the structural point of view,
the presence of aldehyde and phenolic groups enable
vanillin to undergo various chemical transformations.
The 1,10-phenantrolinium salt was prepared via four
simple synthetic steps, including alkylation, reduction,
bromination, and bimolecular nucleophilic substitution
reactions (Figure 1). Initially, vanillin was introduced to

the alkylation reaction using diethyl sulfate as an
alkylating agent to protect the phenolic group which is
prone to reduction reaction (the next step). The product
(4-ethoxy-3-methoxy-benzaldehyde) was obtained in
79% yield.
The protected vanillin underwent reduction reaction
with NaBH4 to give 4-ethoxy-3-methoxy-benzyl alcohol
[18]. The reduction reaction was conducted by grinding
method at rt for a very short period of time, i.e., 10 min,
forming the desired product in a high yield (96%). In
addition, no solvent was employed to facilitate the
reaction. These aspects are in a good agreement with
green chemistry principles [19].
The benzyl alcohol was then converted into the
corresponding benzyl bromide via bromination reaction.
The reaction was performed using an equimolar amount
of phosphorus tribromide under solvent-free condition
to give 4-ethoxy-3-methoxy-benzyl bromide, which was
directly subjected to the last step.
Using the benzyl bromide, we then performed the
bimolecular nucleophilic reaction with 1,10phenantroline as the nucleophile [20]. Finally, we
obtained the desired product, that is, 1-(4-ethoxy-3methoxybenzyl)-1,10-phenanthrolin-1-ium bromide, as
a yellow solid in 58% yield.
After its successful preparation from vanillin, we then
subjected the 1,10-phenantrolinium salt HPIA assay for
the initial evaluation of the phenanthroline derivative as
an antiplasmodium agent. The assay was conducted in
accordance with the method developed by Basilico [17].
The assay showed that the HPIA IC50 of 1-(4-ethoxy-3methoxybenzyl)-1,10-phenanthrolin-1-ium bromide was
3.63 mM, whereas the positive control of chloroquine
yielded the HPIA IC50 of 4.37 mM, which is higher than
that of the phenanthroline salt. Thus, the phenantroline
salt displayed better activity than the commercial drug
chloroquine. The results are in line with the prediction
of antiplasmodium activity using the previously
formulated QSAR equation [16].
Figure 2 illustrates the proposed mechanism of heme
polymerization
inhibition
by
1-(4-ethoxy-3methoxybenzyl)-1,10-phenanthrolin-1-ium bromide.
The free aromatic amine (N10) on the salt may act as a
Lewis base and may interact with Fe(II) of heme (red

Figure 1. Synthesis of 1-(4-ethoxy-3-methoxybenzyl)-1,10-phenanthrolin-1-ium bromide from vanillin
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Figure 2. Proposed Antiplasmodium Activity Interaction
between Heme and 1-(4-ethoxy-3-methoxybenzyl)1,10-phenanthrolin-1-ium bromide

dashed line), thus lowering the reaction rate of
hemozoin formation. Moreover, the benzyl unit derived
from vanillin may play roles in the inhibition of heme
polymerization. The presence of the methoxy group as
an electron-withdrawing group may increase the
positive charge of N1, thus promoting the formation of
hydrogen bond with the oxygen of carboxylate group in
heme (blue dashed line). Other hydrogen bond
interactions (green dashed line) may occur among the
oxygen atoms of ethoxy and methoxy groups with a
hydrogen atom of the heme carboxylate group [8,21].
These interactions may inhibit the heme polymerization
process and the formation of hemozoin, leading to the
death of Plasmodium parasites. Moreover, the soft anion
of bromide (Br−) may aid the salt in penetrating the cell
wall of plasmodium [11].
According to Baelsman, the phenanthroline salt exhibits
a good HPIA because its IC50 value (3.63 mM) is lower
than
37.5
mM.
Therefore,
1-(4-ethoxy-3methoxybenzyl)-1,10-phenanthrolin-1-ium bromide has
a great potential to be developed as an antiplasmodium.

Conclusion
1,10-Phenantrolinium
salt
of
1-(4-ethoxy-3methoxybenzyl)-1,10-phenanthrolin-1-ium bromide was
successfully synthesized from vanillin in four steps:
alkylation, reduction, bromination, and bimolecular
nucleophilic substitution. The HPIA assay showed that
the 1,10-phenantrolinium salt displayed a heme
polymerization activity with the IC50 value of 3.63 mM.
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